secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celcuity Inc. (CELC)
CIK:        0001603454
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001641172-25-021274
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celcuity launches $150M convertible notes + $75M common stock offerings; also to draw $30M loan
--------------------------------------------------------------------------------

- Concurrent underwritten offerings: $150M convertible notes due 2031 and $75M common stock; 30-day over-allotment options for additional $22.5M notes and $11.25M stock.
- Proceeds to fund capped call transactions (reduce dilution on note conversion) and for working capital, clinical trials, R&D.
- Intends to draw $30M Term D Loan in late August 2025 after achieving clinical milestone under existing loan agreement.
- Amended loan with Innovatus/Oxford: $25k fee, extended conversion right on Term A loan to $10/share through May 9, 2026.
- Preliminary cash at June 30, 2025: ~$168.4M (down from $283.1M a year ago).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/0001641172-25-021274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer